The AML Hub was pleased to speak to Lars Bullinger, Charité – Universitätsmedizin Berlin, Berlin, DE, during the European School of Haematology (ESH) 2nd How to Diagnose and Treat: Acute Leukaemia meeting. We asked, What is the optimal gene panel to be assessed for risk stratification?
Lars Bullinger states that the optimal gene panel for risk stratification should comprise genes that aid in the diagnosis, characterization, and monitoring of the disease. The ideal gene panel would include up to 50 genes, such as IDH1/2 genes, and comprise the six molecular markers that are described in the European LeukemiaNet guidelines.